September 9, 2024
The clarification is that it is the nomination committee of Nanologica AB that has presented the proposal to elect Alexandra Blomberg Montgomery to the board of directors of Nanologica AB. The nomination committee, consisting of Carl-Johan Spak (Flerie Invest AB), Lennart Francke (Swedbank Robur funds), and Kalle Olby (Vega Bianca AB), has in connection with [...]
September 9, 2024
Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science reagent suppliers, these appointments will support the execution of the company’s growth strategies and expansion of its commercial operations globally. [...]
Oxford Nanopore announces participation in the PROGRESS study, with Yemaachi Biotech
September 8, 2024
A consortium of Yemaachi Biotech, Pediatric Oncology Units at Korle Bu Teaching Hospital, Komfo Anokye Teaching Hospital and Greater Accra Regional Hospital, and Newcastle University, have come together with Oxford Nanopore to support improved outcomes for childhood leukaemias in Ghana. Oxford Nanopore Technologies (Oxford Nanopore), the company delivering a new generation of molecular sensing technology [...]
September 6, 2024
CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, today announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors. The Series Seed 2 round was led by new investor, LYFE Capital, and existing investor Anzu Partners. New investors including Legend Star, RIT Venture Fund (Rochester [...]
September 5, 2024
DKSH has formed an exclusive partnership with Hygiena, a global leader in food safety and health diagnostics solutions, for their innovative diagnostic solutions. DKSH will leverage its market expansion services to enhance Hygiena’s presence in Cambodia, Laos, and Myanmar. Bangkok, Thailand – DKSH Business Unit Technology enters a new exclusive partnership with Hygiena, a prominent [...]
Qi-biodesign and MGI have reached a strategic cooperation
September 5, 2024
On September 5th, MGI and Qi-biodesign announced a strategic partnership to formally introduce the MGI DNBSEQ-G99 sequencer, the BGI Sequencer nanopore sequencer, etc. The two parties will combine their respective advantages to carry out more extensive cooperation in data analysis methods, protein optimization and microbial data sharing of high-throughput sequencers to promote revolutionary breakthroughs in [...]
Immunocore Selects Genedata to Scale Up Discovery of Novel TCR Therapeutics
September 5, 2024
Basel, Switzerland -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced today that Immunocore (NASDAQ: IMCR), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, will use Genedata‘s central Scientific Data Management System (SDMS) to scale up [...]
September 5, 2024
Boston, US, and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an update from the Company’s work with biopharma company Boundless Bio. SOPHiA GENETICS first partnered with Boundless Bio in 2022 to develop and deploy Boundless Bio’s extrachromosomal DNA (ecDNA) detection algorithm as a [...]
AOByte Works with eLabNext to Streamline Custom Add-On Development
September 5, 2024
BOSTON -- Today, eLabNext, a company that provides digital solutions for the collection, management, and analysis of laboratory information, announced a new collaboration with AOByte, an end-to-end software development service provider. The collaboration between eLabNext and AOByte’s specialized software development tools empowers developers to create both simple and complex add-ons, enhancing the functionality of the digital [...]
SPT Labtech and Synthace partner to accelerate drug discovery through accessible DOE
September 5, 2024
Cambridge, UK, Boston, USA, and London, UK - SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, and Synthace, the leading digital experiment platform for life science R&D teams, have announced a strategic collaboration to enhance the accessibility and effectiveness of Design of Experiments [...]

